Clinical trials with new bicyclic and tetracyclic compounds: zimelidine and maprotiline [proceedings].
D000818:Animals; D000873:Anthracenes / Q000627:therapeutic use*; D001977:Brompheniramine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000188:drug therapy*; D004311:Double-Blind Method; D006801:Humans; D008376:Maprotiline / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D051381:Rats; D015031:Zimeldine
D000873:Anthracenes; D011725:Pyridines; D008376:Maprotiline; D015031:Zimeldine; D001977:Brompheniramine